| Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma. | kidney, |
| Expression of oncoprotein Bcl-2 and bax protein in the infiltration zone and in the parenchyma of primary glia-derived supratentorial neoplasms. | neoplasm, |
| The immunohistochemical expression of BCL-2 oncoprotein in colorectal adenocarcinoma. | colorectal, |
| Coexistence of malignant melanoma, Hodgkin s disease and follicular lymphoma with expression of the B-cell leukaemia/lymphoma (bcl-2) oncogene. | skin,lymphoma, |
| Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. | colorectal, |
| Expression of bcl-2 oncoprotein in Indian oral cell carcinomas. | oral |
| Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity. | lymphoma,leukemia, |
| Expression of BCL-2 oncoprotein on tumor cells and tumor-infiltrating lymphocytes (TIL) in meningiomas. | meningiomas, |
| Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemia. | leukemia, |
| [Bcl-2 oncoprotein expression in head and neck malignant neoplasm]. | neoplasm,HNSC, |
| [The regulation of estrogen and tamoxifen to bcl-2 oncogene in endometrial carcinoma]. | endometrial, |
| Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. | oral |
| A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review). | breast, |
| Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. | brain, |
| DNA ploidy correlates with grade, proliferation and clinical outcome but not with presence of human oncogenic HPVs or expression of Bcl-2 in preneoplastic and neoplastic lesions of the uterine cervix. | uterine, |
| Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer. | nasopharyngeal,laryngeal, |
| Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf. | lung, |
| [The expression of proliferating cell nuclear antigen and Bcl-2 oncoprotein in nasopharyngeal carcinoma]. | nasopharyngeal,laryngeal, |
| Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. | lymphoma, |
| Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma. | kidney, |